Does Helipyl Eradicate
NCT04618159 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2020-11-05
Summary
Helipyl is on the market; actually it is a post-biotic because it is a killed Lactobacillus reuteri DSMZ 17648. The aim is to demonstrate (or not) that this product eradicates helicobacter, which it claims to do.
Conditions
- Eradication
Interventions
- OTHER
-
lactobacillus reuteri DSMZ 17648
to evaluate if this product can eradicate helicobacter pylori
Sponsors & Collaborators
-
Universitair Ziekenhuis Brussel
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 5 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-02-10
- Primary Completion
- 2019-06-01
- Completion
- 2020-01-25
Countries
- Belgium
Study Locations
More Related Trials
-
Oral Antibiotic Treatment of Helicobacter Pylori Reduces Intestinal Colonization Rates With Oxalobacter Formigenes
NCT01300039 ·Status: COMPLETED
-
Effects of H.Pylori Eradication on Microbiome
NCT03231332 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE4
-
Concomitant Infection of Intestinal Parasites and Helicobacter Pylori
NCT05360940 ·Status: UNKNOWN
-
Pathogen-microbiome Interaction During Helicobacter Pylori Infection
NCT05121025 ·Status: RECRUITING
-
Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms
NCT01324726 ·Status: COMPLETED
-
Impact Of Bacterial Resistance On Healthcare Costs For Hospitalized Patients With Complicated Intra-Abdominal Infections
NCT00929643 ·Status: COMPLETED
-
Evaluation of the Antimicrobial Effectiveness of CHG/IPA
NCT04035161 ·Status: COMPLETED
-
One Sequencing Find All for Helicobacter Pylori Infection
NCT03837990 ·Status: UNKNOWN
-
Treatment of Bacterial Vaginosis
NCT00324818 ·Status: COMPLETED ·Phase: PHASE4
-
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
NCT00826670 ·Status: COMPLETED ·Phase: PHASE4
-
Ertapenem in Patients With Urosepsis
NCT03859362 ·Status: UNKNOWN ·Phase: PHASE4
-
Helicobacter Pylori Prevalence in Southern Region of Romania
NCT05874960 ·Status: COMPLETED
-
Empirical Intravenous Beta-Lactam Plus Metronidazole Vs Oral Cefixime Plus Metronidazole for the Treatment of Liver Abscess
NCT06847126 ·Status: RECRUITING ·Phase: PHASE3
-
Recurrent Campylobacter Bacteraemia in Immunocompromised Patients
NCT06432777 ·Status: NOT_YET_RECRUITING
-
Urinary Tract Infections Caused by Extended-spectrum Beta-lactamase-producing Enterobacteria
NCT06910878 ·Status: RECRUITING
-
Role of N-Acetylcysteine in Treatment of Bacterial Vaginosis
NCT01841411 ·Status: UNKNOWN ·Phase: PHASE4
-
GSK2251052 in the Treatment of Complicated Intra-abdominal Infections
NCT01381562 ·Status: TERMINATED ·Phase: PHASE2
-
Study of the Safety, Tolerability, and Efficacy of Relebactam (MK-7655) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone to Treat Complicated Intra-Abdominal Infection [cIAI] (MK-7655-004)
NCT01506271 ·Status: COMPLETED ·Phase: PHASE2
-
Xydalba Utilization Registry in Germany
NCT03696901 ·Status: TERMINATED
-
Phase 1a/b Study on Safety of IMX101 in H. Pylori-negative and H. Pylori-infected Healthy Volunteers
NCT03270800 ·Status: COMPLETED ·Phase: PHASE1
-
Cefoperazone/Sulbactam In The Treatment Of Serious Intra-Abdominal And Hepatobiliary Infections.
NCT00463762 ·Status: WITHDRAWN
-
Efficacy and Pharmacokinetic/Pharmacodynamic Parameters of Cefoxitin in Women With Acute Pyelonephritis Without Severity Symptoms Due to Extended-spectrum β-lactamase Producing Escherichia Coli
NCT01820793 ·Status: TERMINATED ·Phase: NA
-
Biofilms on Short-term Indwelling Ureteral Stents
NCT02845726 ·Status: COMPLETED
-
Ciprofloxacin Plus Metronidazole Vs Cefixime Plus Metronidazole Therapy for the Treatment of Liver Abscess
NCT03969758 ·Status: UNKNOWN ·Phase: PHASE3
-
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
NCT00752219 ·Status: COMPLETED ·Phase: PHASE2